Does a simple hematological examination predict the response and side effects in patients undergoing induction chemotherapy and/or neoadjuvant chemotherapy?

J Chin Med Assoc. 2020 Feb;83(2):107-108. doi: 10.1097/JCMA.0000000000000239.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Chemotherapy, Adjuvant
  • Docetaxel
  • Head and Neck Neoplasms*
  • Humans
  • Induction Chemotherapy
  • Lymphocytes
  • Neoadjuvant Therapy*
  • Neutrophils

Substances

  • Docetaxel